Emerging treatments and combinations in the management of NSCLC: clinical potential of nintedanib

por Reck, Martin, Mellemgaard, Anders
Publicado 2015

First-line treatment of EGFR-mutated nonsmall cell lung cancer: critical review on study methodology

por Sebastian, Martin, Schmittel, Alexander, Reck, Martin
Publicado 2014

Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects

por Peters, Solange, Paz-Ares, Luis, Herbst, Roy S, Reck, Martin
Publicado 2022

Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer

por Normanno, Nicola, Denis, Marc G., Thress, Kenneth S., Ratcliffe, Marianne, Reck, Martin
Publicado 2016

Anesthetic Influence on Occurrence and Treatment of the Trigemino-Cardiac Reflex: A Systematic Literature Review

por Meuwly, Cyrill, Chowdhury, Tumul, Sandu, Nora, Reck, Martin, Erne, Paul, Schaller, Bernhard
Publicado 2015

Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression

por Marwitz, Sebastian, Scheufele, Swetlana, Perner, Sven, Reck, Martin, Ammerpohl, Ole, Goldmann, Torsten
Publicado 2017

Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review

por Garon, Edward B., Visseren-Grul, Carla, Rizzo, Maria Teresa, Puri, Tarun, Chenji, Suresh, Reck, Martin
Publicado 2023

Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial after first-line chemotherapy failure in NSCLC

por Westeel, Virginie, Schuette, Wolfgang, Urban, Thierry, Radonjic, Dejan, von Wangenheim, Ute, Lorence, Robert M., Reck, Martin
Publicado 2023

Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study

por Reck, Martin, Mellemgaard, Anders, Novello, Silvia, Postmus, Pieter E, Gaschler-Markefski, Birgit, Kaiser, Rolf, Buchner, Hannes
Publicado 2018

Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis

por Goldmann, Torsten, Zissel, Gernot, Watz, Henrik, Drömann, Daniel, Reck, Martin, Kugler, Christian, Rabe, Klaus F., Marwitz, Sebastian
Publicado 2018

Epigenetic modifications of the VGF gene in human non-small cell lung cancer tissues pave the way towards enhanced expression

por Marwitz, Sebastian, Heinbockel, Lena, Scheufele, Swetlana, Nitschkowski, Dörte, Kugler, Christian, Perner, Sven, Reck, Martin, Ammerpohl, Ole, Goldmann, Torsten
Publicado 2017

Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy

por Nitschkowski, Dörte, Marwitz, Sebastian, Kotanidou, Sousana A., Reck, Martin, Kugler, Christian, Rabe, Klaus F., Ammerpohl, Ole, Goldmann, Torsten
Publicado 2019

RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small cell lung cancer: exposure–response relationship

por Nakagawa, Kazuhiko, Garon, Edward B., Gao, Ling, Callies, Sophie, Zimmermann, Annamaria, Walgren, Richard, Visseren-Grul, Carla, Reck, Martin
Publicado 2022

Integrated circulating tumour DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma

por Angeles, Arlou Kristina, Janke, Florian, Daum, Ann-Kathrin, Reck, Martin, Schneider, Marc A., Thomas, Michael, Christopoulos, Petros, Sültmann, Holger
Publicado 2023

Fountain of youth for squamous cell carcinomas? On the epigenetic age of non‐small cell lung cancer and corresponding tumor‐free lung tissues

por Marwitz, Sebastian, Heinbockel, Lena, Scheufele, Swetlana, Kugler, Christian, Reck, Martin, Rabe, Klaus F., Perner, Sven, Goldmann, Torsten, Ammerpohl, Ole
Publicado 2018

Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC

por Gaber, Rania, Watermann, Iris, Kugler, Christian, Reinmuth, Nils, Huber, Rudolf M, Schnabel, Philipp A, Vollmer, Ekkehard, Reck, Martin, Goldmann, Torsten
Publicado 2014

An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurren...

por Hellmann, Matthew, Ramalingam, Suresh, Reck, Martin, O'Byrne, Ken, Paz-Ares, Luis, Harbison, Christopher T, Bhagavatheeswaran, Prabhu, Nathan, Faith, Brahmer, Julie
Publicado 2015

Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer

por Marwitz, Sebastian, Ballesteros-Merino, Carmen, Jensen, Shawn M, Reck, Martin, Kugler, Christian, Perner, Sven, Drömann, Daniel, Goldmann, Torsten, Fox, Bernard A
Publicado 2021

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-smal...

por Schuette, Wolfgang, Schneider, Claus-Peter, Engel-Riedel, Walburga, Schumann, Christian, Kohlhaeufl, Martin, Serke, Monika Heidi Ursel, Hoeffken, Gert, Kortsik, Cornelius, Reck, Martin
Publicado 2017

High Aldehyde Dehydrogenase Levels Are Detectable in the Serum of Patients with Lung Cancer and May Be Exploited as Screening Biomarkers

por Rossi, Alessandra, Voigtlaender, Minna, Klose, Hans, Schlüter, Hartmut, Schön, Gerhard, Loges, Sonja, Paolini, Moreno, Bokemeyer, Carsten, Reck, Martin, Tarro, Giulio, Binder, Mascha
Publicado 2019